[{"address1": "1055 Westlakes Drive", "address2": "Suite 300", "city": "Berwyn", "state": "PA", "zip": "19312", "country": "United States", "phone": "610 727 3913", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 72, "title": "Founder, CEO, President & Executive Director", "yearBorn": 1951, "fiscalYear": 2022, "totalPay": 965600, "exercisedValue": 0, "unexercisedValue": 3749000}, {"maxAge": 1, "name": "Mr. Henry  Hagopian III, M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 510049, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.14, "open": 9.19, "dayLow": 9.19, "dayHigh": 10.5, "regularMarketPreviousClose": 9.14, "regularMarketOpen": 9.19, "regularMarketDayLow": 9.19, "regularMarketDayHigh": 10.5, "beta": 1.668, "forwardPE": -3.5266905, "volume": 412554, "regularMarketVolume": 412554, "averageVolume": 307668, "averageVolume10days": 366960, "averageDailyVolume10Day": 366960, "bid": 9.86, "ask": 9.93, "bidSize": 1100, "askSize": 900, "marketCap": 101699392, "fiftyTwoWeekLow": 5.42, "fiftyTwoWeekHigh": 23.89, "fiftyDayAverage": 11.006, "twoHundredDayAverage": 11.8709, "currency": "USD", "enterpriseValue": 95344184, "floatShares": 7393660, "sharesOutstanding": 10262300, "sharesShort": 980189, "sharesShortPriorMonth": 635617, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.0955, "heldPercentInsiders": 0.26388, "heldPercentInstitutions": 0.15583, "shortRatio": 2.4, "shortPercentOfFloat": 0.129, "impliedSharesOutstanding": 10262300, "bookValue": 0.739, "priceToBook": 13.410013, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -41717088, "trailingEps": -4.84, "forwardEps": -2.81, "52WeekChange": -0.46922183, "SandP52WeekChange": 0.21733451, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "ANVS", "underlyingSymbol": "ANVS", "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "firstTradeDateEpochUtc": 1580308200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "e153bc75-9830-375d-bf5e-330db4df878a", "messageBoardId": "finmb_622711087", "gmtOffSetMilliseconds": -18000000, "currentPrice": 9.91, "targetHighPrice": 72.0, "targetLowPrice": 26.0, "targetMeanPrice": 39.8, "targetMedianPrice": 35.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 6354942, "totalCashPerShare": 0.619, "quickRatio": 1.783, "currentRatio": 2.868, "returnOnAssets": -1.24072, "returnOnEquity": -2.27846, "freeCashflow": -23621660, "operatingCashflow": -34211728, "financialCurrency": "USD", "trailingPegRatio": null}]